ADC THERAPEUTICS SA shareholders Q1 2023

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q1 2023. The put-call ratio across all filers is 16.86 and the average weighting 0.2%.

ADC THERAPEUTICS SA shareholders Q1 2023
NameSharesValueWeighting ↓
Citadel Advisors 11,800$23,0100.00%
COMMONWEALTH EQUITY SERVICES, LLC 10,093$190.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 26,028$50,7550.00%
Verition Fund Management LLC 11,241$21,9200.00%
HRT FINANCIAL LP 16,334$310.00%
BARCLAYS PLC 334,272$6520.00%
SIMPLEX TRADING, LLC 165$00.00%
Rockefeller Capital Management L.P. 24,701$480.00%
Tower Research Capital LLC (TRC) 63$00.00%
Focused Wealth Management, Inc 300$5850.00%
NOMURA ASSET MANAGEMENT CO LTD 0$00.00%
TD ASSET MANAGEMENT INC 74,690$145,6460.00%
JANE STREET GROUP, LLC 25,584$49,8890.00%
Cubist Systematic Strategies, LLC 25,046$48,8400.00%
UBS Group AG 11,302$22,0390.00%
OSAIC HOLDINGS, INC. 9,482$18,4900.00%
FMR LLC 80,888$157,7320.00%
US BANCORP \DE\ 300$5850.00%
BANK OF AMERICA CORP /DE/ 1,644,808$3,207,3760.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
External links

This page lists ADC THERAPEUTICS SA's shareholders in Q1 2023. To view ADC THERAPEUTICS SA's shareholder history, click here.